Skip to main content
DRI Healthcare Trust logo

DRI Healthcare Trust — Investor Relations & Filings

Ticker · DHT.UN ISIN · CA23344H1091 LEI · 549300ODFRT58UEWWP28 TSX Financial and insurance activities
Open in API
Filings indexed 324 across all filing types
Latest filing 2026-05-15 Declaration of Voting R…
Country US United States of America
Listing TSX DHT.UN

About DRI Healthcare Trust

https://drihealthcare.com/

DRI Healthcare Trust specializes in global pharmaceutical royalty monetization, operating as an income trust. The Trust focuses on acquiring and owning a diversified portfolio of interests in pharmaceutical royalties, which represent dependable, patent-protected cash flow streams derived from the sales of important medicines. As a pioneer in this field, DRI excels at identifying and completing strategic royalty acquisitions, prioritizing assets that address unmet medical needs, possess long-term patent protection, and demonstrate high growth potential. The Trust acts as a strategic capital allocator, providing flexible financing structures for innovators and offering investors exposure to risk-mitigated therapeutic assets.

Recent filings

Filing Released Lang Actions
Report of voting results.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a "Report of Voting Results" from DRI Healthcare Trust’s annual and special unitholder meeting, detailing vote outcomes on trustee elections, auditor re-appointment, and plan amendments. This fits the definition of Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-15 English
News release - English.pdf
Declaration of Voting Results & Voting Rights Announcements Classification · 96% confidence The document is an announcement of the results of shareholder votes at the annual and special meeting, listing percentages for election of trustees, auditor re-appointment, and plan approvals. This matches the definition of a Declaration of Voting Results & Voting Rights Announcement.
2026-05-15 English
52-109F2 - Certification of interim filings - CFO (E).pdf
Regulatory Filings Classification · 85% confidence The document is a Form 52-109F2 certification letter by the CFO attesting to the review and fair presentation of the interim financial report and MD&A. It contains no substantive financial statements or analysis itself and is solely an officer attestation under National Instrument 52-109. Under the Certification Rule, such attestations should be classified as Regulatory Filings (RNS), not as an Interim Report (IR).
2026-05-14 English
Interim MD&A - English.pdf
Management Reports Classification · 95% confidence The document is titled “Management’s Discussion and Analysis for the three months ended March 31, 2026” and contains narrative discussion of operations, non-GAAP measures, liquidity, capital resources, strategy, and forward-looking information. It is a standalone MD&A supplement to the interim condensed consolidated financial statements, without the full set of audited statements themselves. This matches the definition of a Management Report (code MDA) rather than a full Annual (10-K) or Interim/Quarterly Report (IR) or any other category.
2026-05-14 English
Interim financial statements/report – English.pdf
Interim / Quarterly Report Classification · 92% confidence The document is a full set of unaudited interim condensed consolidated financial statements for the three months ended March 31, 2026, including balance sheet, income statement, cash flows, equity changes, and detailed notes. It clearly constitutes a comprehensive quarterly financial report rather than a brief announcement or certification. Therefore, it falls under the Interim/Quarterly Report category. Q1 2026
2026-05-14 English
News release - English.pdf
Earnings Release Classification · 92% confidence The document is a press‐style announcement dated May 14, 2026 titled “DRI Healthcare Reports First Quarter 2026 Results,” summarizing Q1 key metrics with bullet highlights and tabular financial data. It is an initial earnings announcement rather than the full interim report (the full statements and MD&A are filed separately on SEDAR+). This matches the definition of an Earnings Release (ER). Q1 2026
2026-05-14 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.